Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?
Chad R Ritch1, Peter E Clark, Todd M Morgan
1Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract:
The rate of clinical understaging in non-muscle invasive bladder cancer (NMIBC) after an initial transurethral resection (TUR) is significant, particularly for high-grade disease, and this has a major impact on prognosis. A repeat TUR, 2 to 6 weeks following the initial resection, is recommended in appropriately selected cases to avoid diagnostic inaccuracy and improve treatment allocation. This article summarizes the rationale and indications for performing a repeat TUR in NMIBC and also provides information regarding patient selection and technique.
Related Concept Videos
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi VI: Surgical Management
Imaging Studies VI: Voiding Cystourethrography and Cystography


